# Intravitreal Macugen for Ischaemic Diabetic Macular Oedema

> **NCT01175070** · PHASE4 · COMPLETED · sponsor: **University of Oxford** · enrollment: 30 (actual)

## Conditions studied

- Diabetic Macular Oedema

## Interventions

- **DRUG:** Intravitreal injection of pegaptanib sodium

## Key facts

- **NCT ID:** NCT01175070
- **Lead sponsor:** University of Oxford
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2013-03
- **Final completion:** 2013-03
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2014-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01175070

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01175070, "Intravitreal Macugen for Ischaemic Diabetic Macular Oedema". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01175070. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*